260 related articles for article (PubMed ID: 11564087)
1. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
[TBL] [Abstract][Full Text] [Related]
2. Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells.
Kusadasi N; Koevoet JL; van Soest PL; Ploemacher RE
Leukemia; 2001 Sep; 15(9):1347-58. PubMed ID: 11516095
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
Du Z; Jin H; Cai H; Yang S; Tan WS
Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
[TBL] [Abstract][Full Text] [Related]
4. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
[TBL] [Abstract][Full Text] [Related]
5. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
[TBL] [Abstract][Full Text] [Related]
7. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
[TBL] [Abstract][Full Text] [Related]
8. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone.
Luens KM; Travis MA; Chen BP; Hill BL; Scollay R; Murray LJ
Blood; 1998 Feb; 91(4):1206-15. PubMed ID: 9454750
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.
Ohmizono Y; Sakabe H; Kimura T; Tanimukai S; Matsumura T; Miyazaki H; Lyman SD; Sonoda Y
Leukemia; 1997 Apr; 11(4):524-30. PubMed ID: 9096693
[TBL] [Abstract][Full Text] [Related]
12. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
13. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells.
Piacibello W; Gammaitoni L; Bruno S; Gunetti M; Fagioli F; Cavalloni G; Aglietta M
J Hematother Stem Cell Res; 2000 Dec; 9(6):945-56. PubMed ID: 11177609
[TBL] [Abstract][Full Text] [Related]
14. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
15. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
Gothot A; van der Loo JC; Clapp DW; Srour EF
Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
[TBL] [Abstract][Full Text] [Related]
18. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
19. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
Petzer AL; Zandstra PW; Piret JM; Eaves CJ
J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
[TBL] [Abstract][Full Text] [Related]
20. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
Levac K; Karanu F; Bhatia M
Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]